Pre-Owned Medical Devices Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Pre-Owned 
Medical Devices Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing to the latest  report  by IMARC Group, t i t led  "Pre-Owned 
Medical  Devices Market:  Global Industry Trends, Share,  Size, 
Growth, Opportunity and Forecast 2024-2032,"  the g lobal  pre-
Report owned medical  devices market s ize reached US$ 7.0 Bi l l ion in  2023.
Pre-owned medica l  devices are medical  equipment or  instruments 
Highlight and that  have been previously owned and ut i l ized by heal thcare 
faci l i t ies and medica l  professionals.  
Description They include diagnost ic ,  therapeut ic ,  moni tor ing, surgical ,  and 
imaging devices.  They can be ret i red from a heal thcare faci l i ty  due 
to  upgrades,  requirements,  and changes in  technology.
Request for a  PDF sample of this report:  
https:/ /www.imarcgroup.com/pre-owned-medica l-devices-market /req
uestsample
Report Description
G l ob a l  Pr e - O w ned  M e d i ca l  Dev i ces  M ar ke t  T rend s :
The  i n c r eas ing  r eq u i r em en t  f o r  r em o t e  pa t i en t  m on i t o r i ng  ( R PM )  s o lu t io ns  t o  he lp  h ea l t h ca r e  p r ov ide r s  in  f r ee ing  u p  
r eso u r ce s  f o r  t r ea t in g  c r i t i ca l  an d  e x i s t i ng  pa t i en t s  and  p r ov i d ing  m or e  t i m e ly  and  e f f i c i en t  c a r e  r ep r esen t s  one  o f  t h e  
m a jo r  f ac t o r s  d r i v i ng  t he  dem and  f o r  p r e - owned  m ed ic a l  d ev i ces  a r oun d  t he  wo r l d .  M or eove r ,  t he  su r g ing  p r ev a lenc e  o f  
l i f es t y le  d i s eases  and  v i r a l  i n f ec t i o ns ,  an d  r i s i ng  a g ing  po pu la t i on ,  wh i ch  i s  m o r e  susc ep t i b le  t o  t he se  a i lm en t s ,  i s  
augm en t in g  t he  m a r ke t  g r ow t h .  
I n  add i t i on ,  t he  g r ow ing  usa ge  o f  p r e - own ed  m ed ic a l  de v i ces  by  acad em ic  i ns t i t u t i on s  a nd  r esea r ch  f ac i l i t i e s  f o r  t r a in ing ,  
expe r im en t a t i o n ,  an d  educ a t i ona l  pu r p oses ,  wh ich  a l l ow  s t uden t s  an d  r esea r che r s  t o  g a in  exp e r ien ce  i s  i n f l ue nc ing  t h e  
m ar k e t  po s i t i ve l y .  Apa r t  f r om  t h i s ,  t he  i nc r eas in g  adop t i on  o f  p r e - o wned  m ed ica l  dev i ce s  i n  pub l i c  and  p r i va t e  ho sp i t a l s  
o r  c l in i cs  i n  r u r a l  a r e as  t o  m ake  m ed ic a l  equ ipm en t  m or e  a cce ss ib le  t o  pa t i en t s  i s  p r ope l l i ng  t he  g r ow t h  o f  t he  m ar k e t .
Look i ng  f o rw a rd ,  t h e  mark e t  va l u e  i s  p ro j ec t e d  t o  reach  U S$  16 . 4  B i l l i o n  by  2032 ,  expa nd i ng  a t  a  CAG R  o f  9 . 89%  
dur i ng  20 24 - 2 032 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / pr e - ow ned- med i ca l - dev i ces - mark e t
Type Insights:
• X-ray
• Mammography Machines
• CT Machines
• MRI Machines
• Ultrasound Machines
Report • Nuclear Imaging and Medicine Devices
Segmentation • C-arm Devices
End User Insights:
• Hospitals
• Clinics
Regional Insights:
• North America
• Europe
• Asia-Pacifi c
• Latin America
Report • Middle East and Afr ica
Segmentation
• Advanced Ultrasound Systems
• Block Imaging International Inc.
• Canon Medical  Systems Corporation 
(Canon Inc.)
Competitive 
• EverX Pty Ltd
Landscape • GE HealthCare Technologies Inc (General  
Electr ic Company)
with Key 
• Integrity Medical Systems Inc.
Players • Koninkl i jke Phi l ips N.V.
• Probo Medical LLC
• Siemens Healthineers AG (Siemens AG)
• Soma Tech Intl
How has the global pre-owned medical devices market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global pre-owned medical devices market?
Key What is the impact of each driver, restraint, and opportunity on the global pre-owned medical devices 
market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive pre-
owned medical devices market?
What is the breakup of the market based on the type?
Which is the most attractive type in the pre-owned 
medical devices market?
What is the breakup of the market based on the end 
user?
Which is the most attractive end user in the pre-owned 
medical devices market?
What is the competitive structure of the global pre-
Key owned medical devices market?
Questions Who are the key players/companies in the global pre-owned medical devices market?
Answered in 
the Report
1     P r e f a c e
2  S c o p e  a n d  M e t h o d o l o g y
2 . 1  O b j e c t i v e s  o f  t h e  S t u d y
2 . 2  S t a k e h o l d e r s
2 . 3  D a t a  S o u r c e s
2 . 3 . 1  P r i m a r y  S o u r c e s
2 . 3 . 2  S e c o n d a r y  S o u r c e s
2 . 4  M a r k e t  E s t i m a t i o n
Table of 2 . 4 . 1  B o t t o m - U p  A p p r o a c h2 . 4 . 2  T o p - D o w n  A p p r o a c h
2 . 5  F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
Contents 4  G l o b a l  P r e - O w n e d  M e d i c a l  D e v i c e s  M a r k e t  -  I n t r o d u c t i o n4 . 1  O v e r v i e w4 . 2  M a r k e t  D y n a m i c s
4 . 3  I n d u s t r y  T r e n d s
4 . 4  C o m p e t i t i v e  I n t e l l i g e n c e
5  G l o b a l  P r e - O w n e d  M e d i c a l  D e v i c e s  M a r k e t  L a n d s c a p e
5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6  G l o b a l  P r e - O w n e d  M e d i c a l  D e v i c e s  M a r k e t  -  B r e a k u p  b y  T y p e
6 . 1  X - r a y
6 . 1 . 1  O v e r v i e w
6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 2  M a m m o g r a p h y  M a c h i n e s
6 . 2 . 1  O v e r v i e w
6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
       
6 . 2 . 3  M a r k e t  S e g m e n t a t i o n
6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 3  C T  M a c h i n e s
6 . 3 . 1  O v e r v i e w
6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 3 . 3  M a r k e t  S e g m e n t a t i o n
6 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 4  M R I  M a c h i n e s
6 . 4 . 1  O v e r v i e w
6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of 6 . 4 . 3  M a r k e t  S e g m e n t a t i o n6 . 4 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 5  U l t r a s o u n d  M a c h i n e s
6 . 5 . 1  O v e r v i e w
Contents 6 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 5 . 3  M a r k e t  S e g m e n t a t i o n
6 . 5 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 6  N u c l e a r  I m a g i n g  a n d  M e d i c i n e  D e v i c e s
6 . 6 . 1  O v e r v i e w
6 . 6 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 6 . 3  M a r k e t  S e g m e n t a t i o n
6 . 6 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 7  C - a r m  D e v i c e s
6 . 7 . 1  O v e r v i e w
6 . 7 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 7 . 3  M a r k e t  S e g m e n t a t i o n
6 . 7 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 8  A t t r a c t i v e  I n v e s t m e n t  P r o p o s i t i o n  b y  T y p e     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /p re - ow ned-m ed i c a l - dev i c es -m a r
ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]